GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 89 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,961,000 | +4.1% | 160,182 | +0.4% | 0.00% | 0.0% |
| Q3 2016 | $1,883,000 | +40.4% | 159,599 | +3.6% | 0.00% | 0.0% |
| Q2 2016 | $1,341,000 | +69.3% | 154,094 | +2.6% | 0.00% | +100.0% |
| Q1 2016 | $792,000 | -30.7% | 150,195 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $1,143,000 | -0.9% | 147,358 | +0.6% | 0.00% | -50.0% |
| Q3 2015 | $1,153,000 | -15.3% | 146,524 | -2.5% | 0.00% | 0.0% |
| Q2 2015 | $1,362,000 | -13.6% | 150,283 | +23.8% | 0.00% | 0.0% |
| Q1 2015 | $1,576,000 | -3.8% | 121,391 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $1,639,000 | +50.9% | 120,396 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,086,000 | -32.8% | 121,021 | +1.2% | 0.00% | 0.0% |
| Q2 2014 | $1,617,000 | +63.8% | 119,531 | +20.4% | 0.00% | +100.0% |
| Q1 2014 | $987,000 | -23.8% | 99,276 | +1.9% | 0.00% | -50.0% |
| Q4 2013 | $1,295,000 | +7.4% | 97,467 | -1.9% | 0.00% | 0.0% |
| Q3 2013 | $1,206,000 | +54.4% | 99,369 | +31.7% | 0.00% | +100.0% |
| Q2 2013 | $781,000 | – | 75,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |